488143879	488143879	CD	B-NP	O
|	|	NN	I-NP	O
BHMC	BHMC	NN	I-NP	O
|	|	NN	I-NP	O
85427112	85427112	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1064942	1064942	CD	B-NP	O
|	|	CC	I-NP	O
11/22/2003	11/22/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RENAL	RENAL	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/22/2003	11/22/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/19/2003	11/19/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
KARL	KARL	NNP	B-NP	O
EFRAIN	EFRAIN	NNP	I-NP	O
BRESSER	BRESSER	NNP	I-NP	O
MD	MD	NNP	I-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NNP	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
headache	headache	NN	B-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
1334	1334	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
doxepin	doxepin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Epogen	Epogen	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
every	every	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
8	8	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subqutaneously	subqutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
50	50	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
p.r.n.	p.r.n.	NN	B-NP	O
indigestion	indigestion	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
,	,	,	O	O
Hydrocet	Hydrocet	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Bactroban	Bactroban	NNP	B-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
apply	apply	NN	I-NP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
,	,	,	O	O
Serax	Serax	NN	B-NP	O
15-30	15-30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NNP	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
headache	headache	NN	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
MVI	MVI	NN	B-NP	O
therapeutic	therapeutic	JJ	B-ADJP	O
with	with	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
1	1	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Proscar	Proscar	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
sotalol	sotalol	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Flonase	Flonase	NN	B-NP	O
1-2	1-2	NN	I-NP	O
sprays	spray	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.h.s.	q.h.s.	NN	B-NP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.8	0.8	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Mirapex	Mirapex	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topically	topically	RB	B-VP	O
applied	apply	VBD	I-VP	O
b.i.d.	b.i.d.	NN	B-NP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebs	neb	NNS	I-NP	O
q.	q.	VBP	B-VP	O
6h	6h	CD	B-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
0.06	0.06	CD	B-NP	O
%	%	NN	I-NP	O
2	2	CD	B-NP	O
sprays	spray	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
saturated	saturate	VBN	I-NP	O
fat	fat	NN	I-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
Followup	Followup	NN	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Celso	Celso	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
next	next	RB	B-ADJP	O
available	available	JJ	I-ADJP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Codeine	Codeine	NN	I-NP	O
.	.	.	O	O

ADMITTING	ADMITTING	VBG	B-VP	O
DIAGNOSES	DIAGNOSES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cellulitis	Cellulitis	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Type	Type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

High	High	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Ventricular	Ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Restless	Restless	JJ	B-NP	O
legs	leg	NNS	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Sleep	Sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Recurrent	Recurrent	JJ	B-NP	O
UTIs	UTI	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
ear	ear	JJ	I-NP	O
deafness	deafness	NN	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
TREATMENTS	TREATMENTS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
chief	chief	JJ	I-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
sleepiness	sleepiness	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
daytime	daytime	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
61-year-old	61-year-old	JJ	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
Bugettl	Bugettl	NNP	B-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
on	on	IN	B-PP	O
10/9/2003	10/9/2003	CD	B-NP	O
at	at	IN	B-PP	O
Stongarfo	Stongarfo	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
cellulitis	cellulitis	NN	B-NP	O
was	be	VBD	B-VP	O
improving	improve	VBG	I-VP	O
and	and	CC	I-VP	O
participating	participate	VBG	I-VP	O
in	in	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
until	until	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
became	become	VBD	B-VP	O
progressively	progressively	RB	B-ADJP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
increased	increase	VBN	I-NP	O
swelling	swelling	NN	I-NP	O
of	of	IN	B-PP	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
daytime	daytime	NN	B-NP	O
sleepiness	sleepiness	NN	I-NP	O
____	____	NN	I-NP	O
conversation	conversation	NN	I-NP	O
while	while	IN	B-SBAR	O
eating	eat	VBG	B-VP	O
earlier	earlier	RBR	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
than	than	IN	B-PP	O
previously	previously	RB	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
occasional	occasional	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
lasting	last	VBG	B-VP	O
2-3	2-3	CD	B-NP	O
minutes	minute	NNS	I-NP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
not	not	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
last	last	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
3	3	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
gross	gross	JJ	B-NP	O
hematuria	hematuria	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
frequency	frequency	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
dysuria	dysuria	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
complains	complain	NNS	I-NP	O
of	of	IN	B-PP	O
shoulder	shoulder	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
cramping	cramping	NN	B-NP	O
,	,	,	O	O
constant	constant	JJ	B-ADJP	O
at	at	IN	B-PP	O
4/10	4/10	CD	B-NP	O
,	,	,	O	O
not	not	RB	B-VP	O
improved	improve	VBN	I-VP	O
or	or	CC	I-VP	O
worsened	worsen	VBN	I-VP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
,	,	,	O	O
not	not	RB	B-ADVP	O
better	well	RBR	I-ADVP	O
or	or	CC	O	O
worsened	worsen	VBN	B-VP	O
anytime	anytime	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Rehab	Rehab	NN	B-NP	O
reports	report	NNS	I-NP	O
increased	increase	VBD	B-VP	O
ammonia	ammonia	NN	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
given	give	VBN	I-VP	O
increased	increase	VBN	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
lactulose	lactulose	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
now	now	RB	B-ADVP	O
continuous	continuous	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
times	time	NNS	I-NP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
urinates	urinate	VBZ	B-VP	O
every	every	DT	B-NP	O
1-1/2	1-1/2	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
restless	restless	JJ	B-NP	O
legs	leg	NNS	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2003	2003	CD	I-NP	O
showing	show	VBG	B-VP	O
EF	EF	NN	B-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
new	new	JJ	B-NP	O
light	light	JJ	I-NP	O
chain	chain	NN	I-NP	O
gammopathy	gammopathy	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
panniculitis	panniculitis	NN	B-NP	O
,	,	,	O	O
venous	venous	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
frequent	frequent	JJ	B-NP	O
UTIs	UTI	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
BPH	BPH	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
sleepy	sleepy	JJ	B-ADJP	O
,	,	,	O	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
stay	stay	VB	I-VP	O
awake	awake	RB	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
interview	interview	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
15	15	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
had	have	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
,	,	,	O	O
well	well	RB	B-VP	O
perfused	perfuse	VBN	I-VP	O
and	and	CC	I-VP	O
wrapped	wrap	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
neurologic	neurologic	JJ	B-NP	B-cell_type
exam	exam	NN	I-NP	I-cell_type
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
,	,	,	O	O
sleepy	sleepy	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
dentition	dentition	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
reflexes	reflex	NNS	B-NP	O
throughout	throughout	IN	B-ADVP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
sensation	sensation	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
asterixis	asterixis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
an	an	DT	B-NP	O
intention	intention	NN	I-NP	O
tremor	tremor	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Cardiovascularly	Cardiovascularly	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
____	____	VBD	B-VP	O
1-2	1-2	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
40-45	40-45	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
761	761	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
even	even	RB	B-ADVP	O
to	to	TO	B-PP	O
negative	negative	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
wise	wise	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
provided	provide	VBD	B-VP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
CPAP	CPAP	NN	I-NP	B-protein
and	and	CC	O	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
by	by	IN	B-PP	O
respiratory	respiratory	JJ	O	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adequate	adequate	JJ	B-ADJP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
wise	wise	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
baseline	baseline	NN	I-NP	I-protein
at	at	IN	B-PP	I-protein
4	4	CD	B-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
him	him	PRP	B-NP	O
negative	negative	JJ	B-NP	O
1	1	CD	I-NP	O
liter	liter	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
wise	wise	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
UA	UA	NNP	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
too-numerous-to-count	too-numerous-to-count	JJ	B-NP	O
whites	white	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
Augmentin	Augmentin	NN	B-NP	O
for	for	IN	B-PP	O
presumed	presumed	JJ	B-NP	O
UTI	UTI	NNP	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-NP	O
wise	wise	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
rise	rise	VB	I-VP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
NPH	NPH	NN	I-NP	O
insulin	insulin	NN	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-VP	O
p.o.	p.o.	VB	I-VP	O
glucose	glucose	NN	B-NP	O
control	control	NN	I-NP	O
agents	agent	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
Chimoff	Chimoff	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
wound	wound	NN	B-NP	O
dressing	dress	VBG	B-VP	O
care	care	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
PT	PT	NN	B-NP	O
and	and	CC	I-NP	O
OT	OT	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
:	:	:	O	O
Plan	Plan	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mead	Mead	NNP	I-NP	O
regarding	regard	VBG	B-VP	O
his	his	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
PT/OT	PT/OT	NN	I-NP	O
and	and	CC	I-NP	O
wound	wound	NN	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
needed	need	VBD	B-VP	O
his	his	PRP$	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
mask	mask	NN	I-NP	I-protein
replaced	replace	VBN	B-VP	O
and	and	CC	O	O
humidifier	humidifier	NN	B-NP	O
added	add	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	O
16	16	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
while	while	IN	B-SBAR	O
sleeping	sleep	VBG	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Teddy	Teddy	NNP	I-NP	O
Lands	Lands	NNP	I-NP	O
in	in	IN	B-PP	O
Nephrology	Nephrology	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Dungey	Dungey	NNP	I-NP	O
in	in	IN	B-PP	O
Hematogy	Hematogy	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Rubin	Rubin	NNP	I-NP	O
Lortz	Lortz	NNP	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-2055055	9-2055055	CD	B-NP	O
BFFocus	BFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DUARTES	DUARTES	NNP	B-NP	O
,	,	,	O	O
DARWIN	DARWIN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HAMITON	HAMITON	NNP	B-NP	O
,	,	,	O	O
JOE	JOE	NNP	B-NP	O
JOSEF	JOSEF	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5763073	5763073	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/29/03	11/29/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/9/03	10/9/03	CD	B-NP	O

